Yamada Shinichiro, Hashizume Atsushi, Hijikata Yasuhiro, Inagaki Tomonori, Suzuki Keisuke, Kondo Naohide, Kawai Kaori, Noda Seiya, Nakanishi Hirotaka, Banno Haruhiko, Hirakawa Akihiro, Koike Haruki, Halievski Katherine, Jordan Cynthia L, Katsuno Masahisa, Sobue Gen
Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Innovation Center for Clinical Research, National Center for Geriatrics and Gerontology, Obu, Japan.
PLoS One. 2016 Dec 22;11(12):e0168846. doi: 10.1371/journal.pone.0168846. eCollection 2016.
The aim of this study was to characterize the respiratory function profile of subjects with spinal and bulbar muscular atrophy (SBMA), and to explore the underlying pathological mechanism by comparing the clinical and biochemical indices of this disease with those of amyotrophic lateral sclerosis (ALS). We enrolled male subjects with SBMA (n = 40) and ALS (n = 25) along with 15 healthy control subjects, and assessed their respiratory function, motor function, and muscle strength. Predicted values of peak expiratory flow (%PEF) and forced vital capacity were decreased in subjects with SBMA compared with controls. In SBMA, both values were strongly correlated with the trunk subscores of the motor function tests and showed deterioration relative to disease duration. Compared with activities of daily living (ADL)-matched ALS subjects, %PEF, tongue pressure, and grip power were substantially decreased in subjects with SBMA. Both immunofluorescence and RT-PCR demonstrated a selective decrease in the expression levels of the genes encoding the myosin heavy chains specific to fast-twitch fibers in SBMA subjects. The mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha and peroxisome proliferator-activated receptor delta were up-regulated in SBMA compared with ALS and controls. In conclusion, %PEF is a disease-specific respiratory marker for the severity and progression of SBMA. Explosive muscle strength, including %PEF, was selectively affected in subjects with SBMA and was associated with activation of the mitochondrial biogenesis-related molecular pathway in skeletal muscles.
本研究的目的是描述脊髓延髓肌肉萎缩症(SBMA)患者的呼吸功能特征,并通过比较该疾病与肌萎缩侧索硬化症(ALS)的临床和生化指标来探索其潜在的病理机制。我们招募了患有SBMA的男性受试者(n = 40)和ALS患者(n = 25)以及15名健康对照受试者,并评估了他们的呼吸功能、运动功能和肌肉力量。与对照组相比,SBMA患者的呼气峰值流速预测值(%PEF)和用力肺活量降低。在SBMA中,这两个值均与运动功能测试的躯干子评分密切相关,并随疾病持续时间而恶化。与日常生活活动(ADL)匹配的ALS患者相比,SBMA患者的%PEF、舌压和握力显著降低。免疫荧光和RT-PCR均显示SBMA患者中编码快肌纤维特异性肌球蛋白重链的基因表达水平选择性降低。与ALS和对照组相比,SBMA中过氧化物酶体增殖物激活受体γ共激活因子1-α和过氧化物酶体增殖物激活受体δ的mRNA水平上调。总之,%PEF是SBMA严重程度和进展的疾病特异性呼吸标志物。包括%PEF在内的爆发力在SBMA患者中受到选择性影响,并与骨骼肌中线粒体生物发生相关分子途径的激活有关。